Physician

Todd Fitzgerald Lomelino, MD

According to 2025 Medicare claims, Todd Lomelino, MD (NPI: 1730162413) practices family practice in the San Luis Obispo-Paso Robles, CA market, with the plurality of this provider's patient population coming from San Luis Obispo, CA. This provider's primary affiliated billing organization is LOMELINO MEDICAL GROUP PC (NPI: 1386948073; TIN: 273690492) and primary practice location at 93465-9711. Lomelino is affiliated with the CDHC ACO LLC (ACO ID: A5621), participating under the MSSP model.

Lomelino's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,032 traditional Medicare patients, billed 14,137 HCPCS/CPT codes, and received $661,741 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,818 prescription claims across 489 beneficiaries totaling $503,066 in drug costs, led by Ozempic (Semaglutide). DME data shows 434 claims. Open Payments data shows 4 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $157,187 to $661,741. Similarly, Part D prescription costs have moved sharply higher in recent years, from $206,351 to $503,066. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $30,259 and ending at $22,369.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	519	2,885	$157,187
2016	512	3,289	$165,901
2017	565	3,425	$160,618
2018	609	3,299	$153,683
2019	584	3,378	$165,205
2020	569	3,252	$153,403
2021	525	2,905	$169,486
2022	578	3,028	$184,055
2023	565	2,749	$177,114
2024	1,032	14,137	$661,741

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	399	3,934	$206,351
2016	397	3,958	$212,020
2017	401	3,899	$200,102
2018	436	3,939	$226,784
2019	435	4,167	$261,516
2020	415	4,140	$318,577
2021	394	4,220	$355,562
2022	445	4,648	$439,047
2023	475	5,425	$490,716
2024	489	5,818	$503,066

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	84	393	$22,445
2016	42	357	$11,758
2017	84	396	$10,159
2018	95	527	$12,963
2019	155	608	$17,703
2020	136	516	$19,153
2021	100	421	$17,954
2022	87	359	$13,850
2023	114	393	$19,301
2024	114	434	$17,936

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	307	307	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	497	770	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	614	1,039	$60
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	251	1,641	$40
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	221	3,233	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	80	3,326	$93,169
Eliquis	Apixaban	79	4,045	$75,162
Xarelto	Rivaroxaban	55	3,210	$57,802
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	2,100	$42,816
Januvia	Sitagliptin Phosphate	25	1,465	$24,850

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	47	$3,227
A7031	Face mask interface, replacement for full face mask, each	N	N/R	26	$2,346
A7030	Full face mask used with positive airway pressure device, each	N	N/R	27	$2,110
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	16	34	$1,736
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	16	$1,688

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$88	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Todd Fitzgerald Lomelino, MD?

Tedicare shows public-source Medicare data for Todd Fitzgerald Lomelino, MD (NPI 1730162413), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd Fitzgerald Lomelino, MD have ACO affiliation data?

Todd Fitzgerald Lomelino, MD is shown with ACO affiliation data for CDHC ACO LLC (MSSP, ACO ID A5621).

What billing organization is linked to Todd Fitzgerald Lomelino, MD?

Todd Fitzgerald Lomelino, MD is linked to LOMELINO MEDICAL GROUP PC (billing NPI 1386948073) in the available physician profile data.

Does Todd Fitzgerald Lomelino, MD have Open Payments data?

Todd Fitzgerald Lomelino, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.